Ultrobotix Limited

Ultrobotix Limited

CCSE:PLCN
0.07
CAD
+0.00
(-7.14%)
2.99MMarket Cap
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.01
- -
- -
- -
- -
- -
Basic EPS, GAAP
-0.03
-0.1
-0.08
-0.05
-0.01
- -
- -
Free Cash Flow per Basic Share
-0.01
-0.05
-0.04
-0.02
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-0.01
-0.01
-0.07
-0.09
-0.1
-0.1
-0.06
Tangible Book Value per Share
-0.01
-0.01
-0.07
-0.09
-0.1
-0.1
-0.06
Basic Weighted Avg Shares
22
22
23
24
26
26
30
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-683.33
-779.64
-2,098.97
-1,436.63
-657.14
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-2
-2
-1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-682.29
-977.83
-2,012.37
-1,074.26
-1,019.05
- -
- -
Working Capital
- -
1
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
-2
-2
-3
-3
-2
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -

Capital Structure

USD

•

in mil. unless spec.
Sep'25
Dec'25
Jun'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26
26
43
Market Capitalization
- -
- -
2

Working Capital

USD

•

in mil. unless spec.
Sep'25
Dec'25
Jun'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
1
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
204.01%
1.08%
Free Cash Flow
- -
72.89%
70.59%
Net Income, GAAP
- -
1.73%
-86.92%
Sales/Revenue/Turnover
- -
-20.2%
-100%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
-0.01
-0.01
2025
- -
- -
-0.01
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

CEO
Yoav Bar-Joseph
Full Time Employees
5
Sector
Consumer non-durables
Industry
Beverages: non-alcoholic
Address
PO Box 4250 Rosh Haayin HM Israel 4856602
IPO Date
Mar 3, 2022
Business
Cannibble Food-Tech Ltd. (CSE:PLCN) is an Israel-based food tech company that develops and manufactures proprietary powder-based formulas for premixed foods, beverages, nutritional supplements, and spices enhanced with hemp seeds, hemp protein, cannabidiol (CBD), and tetrahydrocannabinol (THC) where legally permitted; products target the better-for-you segment and include sugar-free, dairy-free, plant-based, non-GMO, keto-friendly, low-carb options such as toppings, sweeteners, cakes, popcorn, desserts, syrups, spreads, gluten-free items, nutraceuticals, and medicinal foods marketed under brands The Pelicann™ and Eshbal du Barili. The company operates through segments of product sales and consulting services, serving recreational, health, wellness, and functional food markets with over 100 developed SKUs of which 32 have been manufactured, featuring innovative process technology for evenly distributing oils, liquids, and ingredients in powder mixes without altering texture. Founded in 2018 and headquartered in Rosh Haayin, Israel, Cannibble conducts operations primarily in North America and Israel with distribution through supermarkets, retailers, and health stores. Recent developments include a November 2025 non-brokered private placement announcing up to $250,000 in funding through convertible notes and warrants to support growth; a July 2025 chief financial officer resignation prompting management changes; and a 2022 non-binding letter of intent to acquire Eshbal Functional Foods, expanding capabilities in gluten-free, sugar-free, vegan, and keto product formulations with Eshbal becoming a wholly-owned subsidiary upon completion.

Company News